Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

QNCX

Quince Therapeutics, Inc.

CIK 0001662774 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$17.49
↑ 0.24 (1.39%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$285.10M
P/E Ratio
-8.63
EPS
-1.68
Dividend Yield
Not covered
52W Position
91%
Beta
-12.83

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
18.19
P/S
Not covered
EV/Revenue
Not covered
ROE
-210.8%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 91%
$0.08$19.26

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$83.98M
Total Assets
$93.52M
Free Cash Flow
-$41.78M

Recent news